Running title: Regulation and quantification of mitochondrial morphology and content.
INTRODUCTION
Mitochondria house enzyme systems for -oxidation of fatty acids, the tricarboxylic acid (TCA) cycle, ketogenesis and oxidative phosphorylation (OXPHOS) and as such are key generators of cellular energy in the form of ATP [1] [2] [3] . In addition, this organelle plays an important role in the physiology of mammalian cells through its involvement in reactive oxygen species (ROS) generation, calcium homeostasis, heat generation and apoptosis induction (see [4, 5] and the references therein). Structurally, mitochondria consist of an outer membrane (MOM) that surrounds the inner membrane (MIM). The MIM is highly folded ("cristae") and encloses the matrix compartment where metabolic enzymes and the mitochondrial DNA (mtDNA) reside [6] [7] [8] [9] . ATP is produced via the combined action of the four MIM-embedded complexes (CI-CIV) of the electron transport chain (ETC) and by the MIM-embedded complex V (CV or the F o F 1 -ATPase) through a chemiosmotic coupling mechanism [3, 9, 10] . Together, CI-CV constitute the oxidative phosphorylation (OXPHOS) system, the proper functioning of which critically depends on the functional and structural integrity of MIM protein and lipid components. Given their role in numerous cellular pathways, it is not surprising that dysfunction of mitochondria is observed in many human pathologies. In principle, there are only two categories of mitochondrial diseases [4] : primary disorders (in which one of the 1200-1500 genes encoding a mitochondrial protein is mutated) and secondary disorders (where mitochondria are dysfunctional for a different reason). In this sense, (progressive) mitochondrial dysfunction has not only been linked to (relatively rare) metabolic disorders but also to normal human aging, neurodegeneration, cancer, diabetes and metabolic syndrome (e.g. [4, 5, [11] [12] [13] [14] [15] [16] ). Although mitochondria display a certain genetic and metabolic autonomy, their function is intricately linked to cellular physiology at the level of ion/metabolite exchange and (retrograde) signaling cascades [10, 17] . In addition, the cellular environment normally supplies mitochondria with (submaximal) substrate concentrations and sustains and controls mitochondrial (ultra)structure and motility ("mitochondrial dynamics).
We and others therefore argued that mitochondrial (patho)physiology, if possible, should be studied in living cells, tissues and organisms (see [4, 5] and the references therein). During the last decade it has become increasingly clear that mitochondrial (dys)functioning, amount, (ultra)structure and subcellular positioning are tightly interconnected (e.g. [18] [19] [20] [21] [22] [23] ).
Furthermore, the functional roles of mitochondria in metabolism and signaling appear to depend on the physical compartmentalization, subcellular localization and motility of the organelles, and vice versa. Clearly, changes in mitochondrial motility, fission and fusion dynamics coincide with phenomena such as bioenergetic adaptation, cellular stress, autophagy and cell death, as well as pathological mechanisms involving mitochondrial dysfunction [24] .
Moreover, mitochondrial morphology and mass can be modulated by various pharmacological treatments ( Table 1) . This has made the topics of mitochondrial dynamics, cellular mitochondrial content and its regulation subjects of intense study. Below, we summarize the current insights into how mitochondrial content is regulated (section 2) and discuss experimental strategies to quantify mitochondrial content (section 3).
REGULATION OF MITOCHONDRIAL CONTENT
One of the main purposes of mitochondria is to provide energy-consuming processes with an adequate supply of ATP. However, under certain conditions, cellular energy demands may exceed the mitochondrial capacity of ATP production, causing mild or severe energy depletion ("energy crisis"). This may either be the result of increased energy expenditure such as with endurance training, or due to a functional mitochondrial defect or mutation, relevant during pathological conditions. During energy crisis, ATP deficiency and/or mitochondrial dysfunction will activate adaptive mechanisms attempting to counterbalance this situation [23, 24, [42] [43] [44] . These interlinked regulatory systems control mitochondrial content at the transcriptional and functional level by modulating mitochondrial biogenesis/degradation, fission/fusion dynamics, motility and/or respiration [23] . Of note, mitochondrial content modulation might not work identically in the various cell types because of their different biological function and mitochondrial morphology (Fig. 1) . This is compatible with the observation that mitochondrial abundance and expression levels of OXPHOS complexes apparently correlate with tissue-and cell-specific requirements of oxidative ATP generation [45, 46] . Below, we briefly discuss the three levels of regulation affecting mitochondrial content in more detail ( Fig. 2) : (i) regulation of mitochondrial biogenesis, (ii) regulation of mitochondrial degradation, (iii) regulation of mitochondrial dynamics.
MITOCHONDRIAL BIOGENESIS
Mitochondrial biogenesis can be defined as division and/or "growth" (e.g. elongation by fusion) of pre-existing mitochondria, serving to increase or replenish mitochondrial biomass [47] . Under physiological conditions, this process is an important adaptive mechanism to accommodate metabolic changes or energy depletion since it increases mitochondrial mass and, as a consequence, mitochondrial bioenergetic capacity. Biogenesis is observed after endurance exercise, cold exposure and caloric restriction but also during conditions of oxidative stress and throughout cell division and differentiation [42, 46, [48] [49] [50] [51] . Furthermore, thyroid hormones are known to increase metabolic rate and mitochondrial enzyme levels in rats [52] , and both pre-and postnatal changes in mitochondrial biogenesis have been documented [53] [54] [55] . For instance, during embryonic development energy metabolism and mitochondrial (ultra)structure are remodeled in parallel [56] . At the early stage of embryogenesis (embryonic day 1), the zygotes contain spheroid mitochondria and depend on OXPHOS after which anaerobic glycolysis gradually takes over and reaches a maximum level following implantation. After this, glycolytic ATP generation becomes progressively less important because mitochondrial biogenesis is triggered and OXPHOS is reinitiated due to vascularization. Mitochondrial biogenesis is generally considered as a long-term adaptive response and not a transient accommodation to short fluctuations in energy supply. The latter can be met by enhancing mitochondrial capacity via posttranscriptional regulation (e.g. phosphorylation, (de)acylation, oxidative modification) and/or expression regulation of only a subset of mitochondrial proteins (e.g. [57] [58] [59] ). In case of genetic mitochondrial disorders, increased mitochondrial biogenesis in skeletal muscle can be diagnostically observed as "ragged red fibres" [60] . In humans, about 1000 genes encoding mitochondrial proteins have been identified (MitoCarta human inventory, Broad Institute). The majority of these genes is located on the nuclear DNA (nDNA) since only 13 of them (all encoding subunits of the OXPHOS system) originate from mtDNA. Nuclear-encoded mitochondrial proteins are guided to their correct location in the outer or inner membranes, the inter membrane space or the matrix (for details see [61] and the references therein). This means that mitochondrial biogenesis requires an intricate control network of transcriptional regulators to properly orchestrate the coordinated expression of mtDNA and nDNA-encoded mitochondrial proteins during mitochondrial biogenesis [58, 62] . This information exchange is triggered by mitochondrial (dys)function, including alterations in MIM membrane potential (), OXPHOS dysfunction and reduced mitochondrial and/or cytosolic ATP levels [63] .
Controlling mitochondrial biogenesis not only involves nuclear-to-mitochondrial communication but also mitochondria-to-nucleus ("retrograde") signaling [64] . Directly below, we discuss the key proteins involved in transcriptional regulation of mitochondrial biogenesis (Fig. 2) .
PGC-1α -One of the major players in mitochondrial biogenesis is the transcriptional coactivatior peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) [65, 66] . PGC-1α was first identified as a regulator of adaptive thermogenesis by regulating the expression of the mitochondrial uncoupling protein-1 (UCP-1) in brown fat [67] . Further research revealed that PGC-1α is highly expressed in mitochondria-rich tissues including heart and skeletal muscle [46, 68] . PGC-1α binds to, and regulates the activities of, several transcription factors and nuclear hormone receptors involved in mitochondrial biogenesis [65] . In this sense, PGC-1α coactivates nuclear respiratory factor-1 (NRF-1) [66] , estrogenrelated receptor alpha (ERRα) [69] and myocyte enhancer factor 2 (MEF2) [70] . Thereby it controls expression of several ETC and other mitochondrial proteins. In addition, PGC-1α is involved in fatty acid metabolism because it regulates peroxisome proliferator-activated receptors (PPARs) (for details see [42, 65] and the references therein).
NRF-1 -NRF-1 is a 68-kDa protein that is ubiquitously expressed in embryonic, fetal and adult tissues, with highest expression in skeletal muscle [47, 71] . It has a central DNA binding domain flanked by a nuclear localization signal and a transcriptional activation domain. NRF-1 binds to the recognition site in the target gene promoter region, as a homodimer, and activates transcription of the gene [72, 73] . NRF-1 DNA binding and trans-activation function is enhanced by serine phosphorylation of its N-terminal domain [74, 75] . NRF-1 recognition sites are found in in the proximal promoter of ubiquitously expressed genes [76] , many of which are involved in mitochondrial biogenesis and metabolism [77] . Expression of a substantial number of nDNA-encoded OXPHOS genes has been linked to NRF-1 activity [78] . Moreover, NRF-1 has been found to regulate expression of key components of the mitochondrial protein import machinery, cytochrome c, and the rate-limiting enzyme in heme biosynthesis, 5-aminolevuline [79] [80] [81] . NRF-1 also regulates transcription factor A, mitochondrial (TFAM) [72] , involved in transcription regulation of mtDNA-encoded genes and mitochondrial genome replication [82] . TFAM is required for the expression of the mitochondrial RNA polymerase (POLRMT) and the transcription factor B (TFB) regulators [83] , two components of the mitochondrial transcription complex. Transcription of mitochondrial ribosomal proteins and tRNA synthases are also regulated by NRF-1 [84] .
Genetic and biochemical analysis revealed that interactions between PGC-1α, NRF-1 and TFAM (co)control mitochondrial biogenesis and respiratory capacity [78] . Mitochondrial biogenesis stimulated by PGC-1α requires functional NRF-1, since a dominant negative NRF-1 allele blocks the function of PGC-1 α [66] . The expression of both NRF-1 and PGC-1α has been found to be reduced in diabetes [85] and both factors have also been shown to be induced as a part of the adaptation of skeletal muscle to exercise training [86] . There are many other examples of mitochondrial content regulation via NRF-1 and associated mechanisms.
For instance, NRF-1 and its downstream factor TFAM is upregulated in cells depleted of mtDNA and in rat hepatocytes following lipopolysaccharide treatment [87, 88] . In both of these model systems increased ROS levels were observed, suggesting that oxidative stress and/or redox changes might trigger mitochondrial biogenesis. It has also been suggested that NRF-1 might control the expression of ETC proteins in response to both extracellular signals and intracellular ATP concentrations [42] . With respect to the latter, another well described route of NRF-1-regulated mitochondrial biogenesis involves activation of AMP-dependent protein kinase (AMPK), a major sensor of cellular energy status [89] [90] [91] . AMPK is activated by AMP, which builds up during low energy (i.e. low ATP) conditions such as nutrient deprivation, physical exercise and/or bioenergetics dysfunction [92, 93] . AMPK activation in response to energy depletion stimulates expression of PGC-1α, triggering activation of NRF-1-mediated gene transcription [66, 94] . Interestingly, AMPK activation by the pharmacological agent 5-aminoimidazole-4-carboxamide riboside (AICAR) has been found to induce NRF-1 transcriptional activity through PGC-1α co-activation in various studies (e.g. [32, 95, 96] ). The latter might explain the positive effects of AICAR in animal models of mitochondrial disease and fibroblast from patients with mitochondrial dysfunction [97, 98] .
Upregulation of both NRF-1 and TFAM in skeletal muscle has also been associated with aging, suggesting that mitochondrial biogenesis is induced to compensate for mitochondrial functional deterioration [99] .
NRF-2 -Another NRF family member, NRF-2, has also been found to regulate gene promoters of ETC subunits [100] . Occasionally, NRF-1 and NRF-2 recognition sites are present in the same promoter regions, suggesting that these factors act together in coordinating protein expression in relation to mitochondrial biogenesis (see [94] and the references therein).
PPARs -
The PPAR family of ligand-activated transcription factors comprises several isoforms including PPARα, PPARβ and PPARγ [101] . These variants display different tissuespecific expression patterns and coordinate the expression of metabolic genes involved in glucose and lipid metabolism [101, 102] . PPARs heterodimerize with the retinoid X receptor (RXR), and trans-activate target genes with compatible responsive elements in the promoter region encoding both mitochondrial and non-mitochondrial proteins. However, to the best of our knowledge, PPARs have not been directly associated with expression of ETC components [42] . PPARs are typically activated by long-chain fatty acids and their metabolites [103] . The PPARα isoform is expressed in cells with high rates of mitochondrial fatty acid oxidation, such as liver, heart, kidney and skeletal muscle, intestine and pancreas [101, 104] . The PPARβ isoform is ubiquitously expressed, and has been implicated in fatty acid oxidation as well as other mitochondrial processes [105, 106] . PPARγ is abundantly expressed in adipose tissue and at lower levels in skeletal muscle, liver, heart and bone marrow stromal cells, and regulates glucose metabolism and insulin sensitivity, and UCP-1-mediated thermogenesis [107] .
ERRs -ERR transcription factors are involved in gene regulatory control networks involved in energy homeostasis, including fat and glucose metabolism as well as mitochondrial biogenesis and function [42, 108, 109] . Similar to PPARs and NRFs, ERRs are also coactivated by PGC-1α and expressed in tissues with high energy demands.
MITOCHONDRIAL DEGRADATION
Mitochondrial quality control occurs at the level of organelle and protein integrity and is carried out via mechanisms that identify the compromised components and marks them for destruction, followed by the subsequent recruitment of the machinery responsible for their degradation [11, 13, [110] [111] [112] [113] . Quality control of mitochondrial proteins is described in detail elsewhere (e.g. [11, 114] ). The specific degradation of dysfunctional mitochondria ("mitophagy") is carried out by the lysosomal-autophagic machinery after the dysfunctional organelles have been marked for destruction. Key mediators of mitophagy include the PTEN (phosphatase and tensin homolog)-induced putative kinase 1 (PINK1), presenilin-associated rhomboid-like (PARL) protein and Parkin, a component of a multiprotein E3 ubiquitin ligase complex. PINK1 is normally located on the MOM, but is found at relatively low amount due to its continuous degradation by mitochondrial proteases [115] [116] [117] . Under conditions of (full) mitochondrial depolarization, this proteolytic activity is (fully) blocked leading to PINK1 accumulation on the MOM. When present at this location, PINK1 recruits cytoplasmic Parkin.
This process therefore serves as a quality control mechanism for detecting and tagging dysfunctional mitochondria, with low membrane potential, for degradation by mitophagy/autophagy. Interestingly, evidence was provided that Parkin also regulates the mitochondrial fission/fusion balance (see below) by ubiquitylation of fusion-promoting proteins (Mitofusins) on the MOM [118] . Mitochondrial fission is required to segregate dysfunctional mitochondria from the functional mitochondrial population and allow mitophagy. The current mechanism proposes that dysfunctional mitochondria have a (partially?) depolarized  and, as a consequence, are trapped in autophagosomes for further lysosomal degradation. Mutations in the genes encoding PINK1 or Parkin have been implicated in early onset autosomal recessive Parkinson's disease, suggesting that mitochondrial quality control is of significance in this neurodegenerative pathology [119, 120] . Another protein involved in Parkinson's disease, α-synuclein, also appears to play a role in mitochondrial quality control. However, the nature of this involvement is currently not fully understood [121] [122] [123] . Obviously, mitochondrial biogenesis and degradation by mitophagy act antagonistically, but at the same time complementary; and together they determine net mitochondrial content and mitochondrial quality. However, experimental evidence suggests that mitochondrial biogenesis and autophagy are also more directly connected via the Parkin Interacting Substrate (PARIS) protein [124] . PARIS appears to be a repressor of PGC-1α by inhibiting its expression thereby inhibiting mitochondrial biogenesis.
On the other hand, being a Parkin substrate, PARIS is degraded by the proteasome upon Parkin activation. A mechanism was proposed in which reduced Parkin expression/activity, as observed in Parkin-associated Parkinson's disease, leads to increased PARIS levels thereby affecting the balance between mitochondrial biogenesis and mitophagy [124] . Such a mechanism might amplify the negative effect of Parkin mutations on mitochondrial quality control [116] . In addition to the Pink1/Parkin system, several other proteins (e.g. valosincontaining protein (VCP), the p62 protein, microtubule-associated protein 1 light chain (LC3), the Bcl2/adenovirus E1B 19-kDa protein-interacting protein 3 (Bnip3), the mitochondrial voltage-dependent anion channel (VDAC) and the Nix protein) have been implicated in mitophagy induction, regulation and execution but these are discussed elsewhere [125] [126] [127] [128] .
MITOCHONDRIAL DYNAMICS
Mitochondrial morphology varies between different cell types, ranging from bean-shaped individual organelles to reticular structures ( Fig.1 ). For example, in healthy rat hepatocytes mitochondria are evenly distributed throughout the cell and their structure is generally spherical/ovoid (e.g. [129] ). Mitochondrial reticular assemblies generally extend throughout the cytosol and are often closely juxtaposed to other cellular compartments like the nucleus and endoplasmic reticulum [130] [131] [132] . Mitochondrial morphology is, however, very dynamic and can shift between fragmented structures and tubular networks, via altering the balance between mitochondrial movement, fission and fusion events [133] . This balance determines the net morphology of the cellular mitochondrial population and is controlled by the activities of a growing set of "mitochondria-shaping" proteins ( Fig.2 ; [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] ). In mammals key proteins include mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2), involved in MOM fusion; OPA1 (optic atrophy protein 1; MIM fusion), dynamin-related protein 1 (Drp1; MOM fission), and Fission protein 1 (Fis1; a Drp1-adaptor protein); and Miro and Milton (both involved in mitochondrial motility). At the posttranslational level, the activities of mitochondrial fusion/fission proteins is regulated by an collection of regulatory components ( Fig. 2 ; details provided in [20, [143] [144] [145] [146] [147] [148] ). Interestingly, mitochondrial fusion and fission proteins also are directly involved in regulation of mitochondrial functional properties, strongly suggesting that mitochondrial shape, spatiotemporal localization and function are linked [135, 140, [149] [150] [151] [152] [153] [154] [155] .
For instance, fragmentation and fusion events, and therefore also membrane remodeling, occurs both in response to metabolic influence and as part of cell death programs [135, 156, 157] . Moreover, Mfn2 loss-of-function inhibited pyruvate, glucose and fatty acid oxidation and induced mitochondrial depolarization [158] . In contrast, Mfn2 gain-of-function increased glucose oxidation and mitochondrial membrane potential. This suggests that Mfn2 (co)regulates mitochondrial function through a mechanism independent of its role in mitochondrial fusion. The mitochondrial volume fraction in the cell depends on the cell type and metabolic condition [159, 160] . In this sense, multiple mitochondrial abnormalities may be observed in muscle and skin cells of patients with inherited mitochondrial disorders (e.g. [161, 162] ). Similarly, when mitochondrial function was chronically inhibited by rotenone, a specific blocker of the first ETC complex (CI), mitochondrial length and degree of branching dose-dependently increased [37, 163] . In the light of the above, and given the fact that mitochondrial shape and mass also can differ within and between the same cell type (e.g. [149, 150, 162] ), a proper understanding of the relationship between mitochondrial content, shape and function requires statistical analysis. For this purpose functional and microscopybased strategies have been developed, which are discussed in the following sections.
QUANTIFICATION OF MITOCHONDRIAL MORPHOLOGY AND CONTENT
Methods to evaluate mitochondrial function have been a topic of major interest in experimental research, pharmacological screening and clinical diagnostics. There are multiple experimental approaches to measure individual or composite mitochondrial properties.
Common analyses include biochemical measurements of mitochondrial marker proteins and enzyme activities, quantitation of mtDNA level and fluorescence microscopy analysis [40, 45, 164, 165] . Also (cryo)-electron microscopy (EM) analysis of fixed specimens has been widely applied to analyze mitochondrial (ultra)structure (e.g. [41, [166] [167] [168] ). As a consequence, morphometric analyses have been historically important to quantify mitochondrial properties using EM images [169] . New developments in the EM field, including tomography and image processing tools, have extended the analytic potential by enabling 3D-reconstruction, detection and segmentation of mitochondria, which has proven to be powerful methods to study mitochondrial internal and external structure. Additional information regarding EM analysis of mitochondrial (ultra)structure can be found elsewhere [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] . Below we discuss three other methodological approaches to assess mitochondrial morphology and/or content in biological samples: (i) bioenergetic capacity, (ii) biochemical biomarkers, and (iii) fluorescence microscopy analysis.
MITOCHONDRIAL BIOENERGETIC CAPACITY
Quantification of oxygen consumption rates is frequently used to assess mitochondrial oxidative capacity and thereby mitochondrial content in isolated mitochondria and (permeabilized) cells and tissue samples (e.g. [38] [39] [40] [181] [182] [183] [184] [185] ). The strategy of isolating mitochondria from human and animal tissue/cell material has historically been very important, and the technique was pioneered by scientists such as Chance and Williams [186] .
Analysis of mitochondria-enriched fractions led to the formulation of Mitchell's chemiosmotic theory [3] and the subsequent elucidation of other mitochondrial metabolic pathways like the TCA cycle [187] . Currently, optimized protocols for mitochondrial isolation from a variety of tissues and cells are available (e.g. [188, 189] ). However, isolated mitochondria are relatively fragile and their morphology and function differs with that observed in living cells [190] . The latter relates to the fact that in situ mitochondrial function is closely linked to cell metabolism and associated with submaximal rates of mitochondrial enzyme activity. Moreover, as explained above, the cellular environment mediates communication between mitochondria the cytosol and other organelles during forward and retrograde mitochondrial signaling [154] . This means that data obtained with mitochondria-enriched fractions is not necessarily informative about mitochondrial (patho)physiology at the cellular and tissue level. To overcome some of the adverse effects caused by the isolation procedure, permeabilization of the cellular membrane has been used as an alternative procedure to access mitochondrial activities. Using this method, mitochondrial function can be studied without dislocating the organelles from the intracellular compartment, and the metabolic conditions and substrate concentrations can still be controlled [181, 191] . However, the nature and significance of mitochondrial changes taking place during subcellular isolation is still under debate [192] .
BIOCHEMICAL BIOMARKERS
Another common method to determine mitochondrial content involves analysis of the protein levels of (a collection of) mitochondrial proteins such as OXPHOS subunits and/or membrane transporters in cell or tissue lysates (e.g. [25, 40] ). Similarly, analysis of individual enzyme activities under non-substrate limiting (Vmax) conditions generally reflects the levels of mitochondrial OXPHOS proteins (e.g. [193] ). Indeed, analysis of cells from patients with isolated CI deficiency, maximal CI enzymatic activity and the amount of fully-assembled CI (determined by native gel electrophoresis) proportionally declined [194] . However, mitochondrial content was not reduced in these cells [150] , demonstrating that OXPHOS protein levels and Vmax values not always reflect mitochondrial content. An alternative strategy to analyze mitochondrial biogenesis and content involves quantification of mRNA levels of nDNA-encoded genes of OXPHOS subunits and mitochondrial transcription regulators (e.g. [40, 183] ). Furthermore, recent progress in real-time quantitative PCR technology has enabled sensitive analysis of mtDNA copy number in small sample volumes [195] . By this method mtDNA content is quantified relative to nDNA, yielding a mitochondrial-to-nuclear DNA ratio as measure of mtDNA copy number, which was used as a measure of mitochondrial content in animal and clinical studies [40, [196] [197] [198] . It should, however, be mentioned that changes in OXPHOS protein expression or mtDNA levels do not always correlate with changes in mitochondrial content (e.g. [199, 200] ). The expression level and/or the activity of citrate synthase, a mitochondrial matrix enzyme, is commonly used as a reference when evaluating relative changes in mitochondrial properties or as a surrogate marker of total mitochondrial volume and content (e.g. [193] ). The protein amount of several marker enzymes can also be evaluated using histochemical staining of tissue preparations, including nicotinamide adenine dinucleotide tetrazolium reductase [201] , cytochrome c oxidase [202] and succinate dehydrogenase [203, 204] .
FLUORESCENCE MICROSCOPY
Microscopy techniques have been essential in mitochondrial research since the discovery of these organelles back in the 1840's [205] . Nowadays, mitochondrial analysis by live-cell microscopy represents the most direct method to retrieve authentic information about mitochondrial shape, position and content. Development of superresolution microscopy techniques has allowed imaging of fluorescently labeled cells and organelles at unprecedented levels of resolution [206] [207] [208] [209] [210] [211] [212] . For example, using three-dimensional (3D) structuredillumination microscopy (SIM) resolution was doubled relative to a wide-field fluorescence microscope yielding values of 120 nm (lateral) and 360 nm (axial). The SIM approach allowed live-cell recordings of mitochondrial (ultra)structure in living cells at up to 5 s per volume for >50 time points [213] .
Visualization of mitochondria by live-cell microscopy -Mitochondria in living cells are generally visualized using chemical and/or proteinaceous fluorescent reporter molecules ("probes"; Fig. 1 ; [214, 215] ). Chemical probes can be introduced into the cells using specific incubation protocols whereas protein-based probes require cell transduction or transfection. 
Quantification of mitochondrial morphology and content using image analysis -With
respect to mitochondrial content, the fractional cellular volume occupied by mitochondria has been measured based on fluorescence detection of mitoGFP and calcein blue in the cytosol [224] . Alternatively, we and others have developed procedures allowing systematic analysis of mitochondrial shape, number and mass using fluorescence microscopy images ( Table 2 ).
This can be carried out using for example the freely available Fiji (http://pacific.mpicbg.de/wiki/index.php/Main_Page) or OpenCV software (www.opencvb.org) or commercial programs like Matlab (www.mathworks.com) or Image Pro Plus (www.mediacy.com).
Automated methods generally apply an image processing algorithm ("pipeline"; Fig. 3A) , which involves highlighting the position of mitochondrial structures by generation of a binary (BIN) image (segmentation), followed by masking of the background-corrected original image (COR) using this BIN image. From the BIN image (representing white mitochondrial objects on a black background) various mitochondrial parameters ("descriptors") can be extracted. These descriptors include the number of mitochondria per cell (Nc), the mean area of individual mitochondria (Am), the mitochondrial mass (which can be approximated in cells with a relatively flat morphology by the product of Nc and Am; [219, 222] or by summing up all values of Am within a given cell), mitochondrial aspect ratio (AR, a measure of mitochondrial length) and mitochondrial formfactor (F, a combined measure of mitochondrial length and degree of branching; [37, 149] ). In principle, when combined with an automated high-throughput microscopy system the above pipeline allows for automated high-content, high-throughput, screening [4, 5, 254] . To illustrate our quantitative approach we segmented the mitochondria for various images depicted in figure 1. Visual inspection of the resulting BIN images (Fig. 3B ) reveals that the above processing pipeline, originally developed for R123-stained primary human skin fibroblasts [37, 222] , gave correct results for 7 out of 10 conditions (Fig. 3C, green bars) . However, mitochondrial segmentation was not successful in panels Bh, Bn and Br, thereby yielding erroneous values for Nc, Am, mitochondrial mass, AR and F (Fig. 3C, red bars) . This means that prior to implementation of automated processing and quantification, a pipeline should be manually validated for the given cell type by visual inspection. Once the experimental conditions for successful automated quantification have been established for a certain cell type, images yielding erroneous descriptor values can be automatically identified and discarded from the analysis by comparing their descriptor values with the cell population average. The above results clearly demonstrate that a certain experimental strategy (e.g. cell type, mitochondrial probe, microscopy hardware, image acquisition procedure) requires a tailor-made processing/analysis pipeline (and vice versa).
Crucially, it is important to realize that image magnification/resolution (i.e. the used microscopy objective) and signal-to-noise (S/N) ratio need to be compatible with the size of the (small) mitochondrial objects and the to-be designed processing protocol [37, 162, 222] .
As an example of quantification of mitochondrial content (i.e. mass) in 2D microscopy images, we have previously developed a high-content strategy for primary human skin fibroblasts [220, 222] . Mitochondrial mass in these cells can be approximated by multiplying the number of mitochondria per cell (Nc) by the mean mitochondrial area (Am) of the mitochondrial objects. This strategy is particularly applicable to fibroblasts and other cell types with a flat morphology since in this case the lateral cell dimensions (area) greatly exceed its axial dimensions (height). Under these conditions the total mitochondrial volume can be approximated by the total mitochondrial area (i.e. the product of Nc and Am). To demonstrate the application of this approach we investigated the effect of changes in cellular metabolic state on mitochondrial shape and mass. Therefore healthy primary skin fibroblasts were cultured for 24 h in normal glucose-containing medium (GLU) and medium in which the glucose was replaced by galactose (GAL) and dialyzed serum was used (Fig. 4) . In cancer cells, this maneuver shifts energy metabolism from glycolysis towards OXPHOS-mediated ATP generation [255] . Visual comparison of typical live-cell microscopy images suggests that GAL treatment induces mitochondrial fragmentation (Fig. 4A vs. Fig.4B) . Image segmentation based upon Am [219] followed by visual inspection suggests that mitochondria become smaller in GAL-treated cells (Fig. 4C) . A more complete analysis for a population of cells revealed that GAL treatment does not affect Nc, but significantly reduces Am, mitochondrial mass, AR and F. These results suggest that 24 h GAL treatment does not induce mitochondrial fragmentation (i.e. Nc is not affected) but leads to mitochondrial shrinkage and a reduced mitochondrial mass. However, since we used a -dependent R123 staining for mitochondrial visualization, we cannot rule out that GAL treatment induces  depolarization to such extent that mitochondria are "missed" in the analysis. Importantly, the reliability of using the product of Am and Nc as a measure of mitochondrial mass also depends on cell size. This is caused by the fact that larger cells generally contain more and larger mitochondrial objects. For instance, in the case of primary skin fibroblasts from patients with isolated CI deficiency we analyzed 2D images of cells stained with CM-DCF (chloromethyl-2',7'-dichlorofluorescein; see [256] for protocol). This ROS probe is localized in the cytosol and revealed that control cells have a size of 100±15% (N=27 cells; CT5120 cell line) whereas a size of 183±15% (N=19) was found in a patient cell line (P5171). Similarly, mitochondrial mass in P5171 cells was 194% of that in CT5120 cells (Fig. 5A, Fig. 5B ), demonstrating that mitochondrial mass measurements should be accompanied by cellular size quantification. If fluorescent cations are used for mitochondrial staining, some fluorescence signal might be originating from the cytosol leading to a distinct peak in the intensity histogram (Fig. 5C) . In this case, image processing can be used to segment the cytosolic compartment using thresholding (T) and median filtering (MED; Fig. 5D ). Superposition of the mitochondrial BIN image (Fig. 5B) and cytosolic MED image using a Boolean "AND" operation (similar to Fig. 3A) , can then be used to calculate the mitochondrial mass corrected for cellular size (i.e. the ratio between the total mitochondrial area from the BIN image and the total cytosolic area from the MED image). The result of this procedure ( Fig. 5D ; "BIN AND MED" image) depicts mitochondria (light blue) within the cytosol (dark blue).
Interpretation of quantitative data for mitochondrial morphology and content in 2D
microscopy images -In case of primary skin fibroblasts from patients with isolated CI deficiency, we observed that individual mitochondria appeared fragmented and/or less branched in patient fibroblasts with a severely reduced CI amount and activity (class I), whereas patient cells in which these latter parameters were only moderately reduced displayed a normal mitochondrial morphology (class II; [150] ). Comparing these mitochondrial morphology alterations with other cellular and mitochondrial readouts revealed that, relative to class II patients, class I patients displayed an earlier age of disease onset and death, a larger reduction in CI enzymatic activity, a greater increase in NADH/ROS levels and lower cellular levels of OXPHOS proteins [257] . With respect to ROS signaling, we provided evidence that mitochondrial morphology and function are controlled by endogenous ROS and redox signaling [38, 228] . A recent conceptual model [20, 148] proposes that mitochondria can exist in three morphological "states" of net morphology: (i) a filamentous or "hyperfused" state, (ii) an intermediate or "normal" state, and (iii) a fragmented state (Fig. 6A) . These morphologies have been linked to distinct cellular and mitochondrial metabolic states and conditions, supporting the model that mitochondrial function determines mitochondrial morphology and vice versa [20, 148, [258] [259] [260] . Each of the three morphological states was associated with a distinct phenotype of mitochondrial parameters in primary human skin fibroblasts (Fig. 6B) .
Combining this multivariate dataset with its associated "biological" meaning ( Fig. 6C) allowed correct classification of the observed phenotypes. Of note, using multiple mitochondrial parameters allows not only for identification of "classical" filamentous and fragmented morphologies but also is able to identify mitochondrial elongation, shrinkage, biogenesis and increased fusion/fission (Fig. 6C). 3D analysis of mitochondrial morphology and content -Automated quantification of mitochondrial morphology and content has been most successful using wide-field or confocal 2D images ( Table 2) . For reasons explained above this strategy is less applicable to thicker specimens [222] . However, a "semi-3D" image can be created by collapsing multiple imagesections from a wide-field or confocal z-stack into a single 2D projection [224, 261] . A more advanced strategy consists of calculating a 3D representation of the mitochondrial compartment from the z-stack and performing a 3D analysis of mitochondrial number, morphology (e.g. sphericity) and content (e.g. total volume). Although the technical requirements for image acquisition, processing and analysis are significantly more demanding than for 2D procedures, recent attempts to analyze mitochondria in 3D have demonstrated that this strategy has promising potential [247] . The latter study as well as others (e.g. [249] ) demonstrated that additional mitochondrial subtyping (i.e. using more than the three categories described above) may also be applied to account for differences in shape and appearance. Thus, the descriptors to be analyzed should depend on the physiological or experimental context in the particular study, and whether it is the mitochondrial fragmentation state or other shape changes that are of interest.
SUMMARY AND CONCLUSIONS
Until recently, changes in mitochondrial content were explained primarily in terms of mitochondrial biogenesis or proliferation, without accounting for removal of damaged organelles. However, the cellular mitochondrial content under a given condition results from the balance between mitochondrial biogenesis, dynamics and degradation. Since mitochondria represent primary sites of both metabolism and cell signaling, they serve as sensors, effectors, 
ABBREVIATIONS
 , mitochondrial membrane potential AICAR, 5-aminoimidazole-4-carboxamide riboside Am, the area of individual mitochondris AMPK, AMP-dependent protein kinase AR, mitochondrial aspect ratio BIN, binary image BNIP3, Bcl2/adenovirus E1B 19-kDa protein-interacting protein 3 CM-DCF, chloromethyl-2',7'-dichlorofluorescein COR, background-corrected microscopy image Drp1, dynamin-related protein 1 EM, electron microscopy ERRα, estrogen-related receptor alpha ETC, electron transport chain F, mitochondrial formfactor Fis1, fission protein 1 GFP, green fluorescent protein JC-1, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl-carbocyanine MIM, mitochondrial inner membrane MED, median (filtered) image MEF2, myocyte enhancer factor 2 Mfn1/2, mitofusin 1/2 MOM, mitochondrial outer membrane mtDNA, mitochondrial DNA Nc, number of mitochondria per cell nDNA, nuclear DNA NRF-1, nuclear respiratory factor-1 NRF-2, nuclear respiratory factor-2 OPA1, optic atrophy protein 1 OXPHOS, oxidative phosphorylation PARIS, parkin interacting substrate PARL, presenilin-associated rhomboid-like PGC-1α, peroxisome proliferator-activated receptor gamma coactivator-1α PINK1, PTEN (phosphatase and tensin homolog)-induced putative kinase POLRMT, mitochondrial RNA polymerase PPAR, peroxisome proliferator-activated receptor R123, rhodamine 123 ROS, reactive oxygen species RXR, retinoid X receptor SIM, structured-illumination microscopy S/N, signal-to-noise T, thresholding, thresholded TCA, tricarboxylic acid cycle TFAM, Transcription factor A, mitochondrial TFB, transcription factor B TMRE, tetramethylrhodamine ethyl ester TMRM, tetramethylrhodamine methyl ester UCP-1, uncoupling protein-1 VCP, valosin-containing protein VDAC, voltage-dependent anion channel threshold operation (T), the image is median-filtered (MED; 3x3 filter size, 3 times) and combined with the BIN image in panel B using a Boolean "AND" operation (BIN AND MED). The latter figure depicts mitochondria (light blue) within the cytosol (dark blue). The total number of mitochondrial pixels equaled 4056290 (i.e. 9.54% of the total number of cytosolic pixels equaling 42513000). 
HM-R123
MSF-R123
RPAC-R123
HMT-JC1 BGM-mitoEYFP AFM, atomic force microscopy; Algo, mitochondrial morphology quantification algorithm; Am, mitochondrial area (size); AR, aspect ratio; BP, mitochondrial branching points; C9, clone 9 rat liver cell; CEA, chicken embryo astrocytes; CEH, chicken embryo hepatocytes; CEMC, C. elegans muscle cells; CEMN, chick embryo motor neurons; CHO, Chinese hamster ovary; CLSM, confocal laser scanning microscopy; CV1, monkey kidney fibroblast cells; decon, deconvolution; F, formfactor; F/Nc, mitochondrial complexity; GRP75, mitochondrial heatshock protein 70 (mtHSP70); H9c2, cardiac myoblast cell; HUVEC, human umbilical vein endothelial cell; IMEF, immortalized mouse embryonic fibroblast; IRHM, isolated rat heart mitochondria; MitoEYFP, mitochondria-targeted enhanced yellow fluorescent protein; MitoGFP, mitochondria-targeted green fluorescent protein; MitoroGFP2, mitochondria-targeted redox-sensitive green fluorescent protein 2; M17HN, M17 human neuroblastoma; MM, malignant mesothelioma; n.a., not appropriate; N2a, mouse neuroblastoma cell line; Nc, number of mitochondria per cell; NPC, mitochondrial networks per cell; P, mitochondrial perimeter; PC12, rat pheochromocytoma cell; PHMyob, primary human myoblasts; R123, rhodamine 123; RCN, rat cortical neurons; PHSF, primary human skin fibroblasts; PMEF, primary mouse embryonic fibroblast; RFP, red fluorescent protein; SH-SY5Y, human dopaminergic neuroblastoma clonal cell; TMA, total mitochondrial area; TMRM, tetramethylrhodamine methylester; U2OS, human osteosarcoma cell line; V, mitochondrial volume.
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